Unleashing Raw Pharma Thoughts
When working remotely and having to manage your own time, it is not uncommon for breaks to be overlooked. A new survey by the online scheduling platform Doodle confirms the US workforce’s collective neglect of breaks. 72% of US employees admit to feeling
Explore Pharmaceutical Industry with Samir
When working remotely and having to manage your own time, it is not uncommon for breaks to be overlooked. A new survey by the online scheduling platform Doodle confirms the US workforce’s collective neglect of breaks. 72% of US employees admit to feeling
Unveiling the Real Corporate Career Growth Secrets
When working remotely and having to manage your own time, it is not uncommon for breaks to be overlooked. A new survey by the online scheduling platform Doodle confirms the US workforce’s collective neglect of breaks. 72% of US employees admit to feeling
The Myths about the Pharmaceutical Industry
The word “myth” is defined in the dictionary as “a widely held but false belief or idea.” In other words it’s a lie that everybody treats as truth. The validity of the statement is accepted even if it’s not true. Then the statement
The Pharma Do Cure – Many Diseases, Permanently!
“I’m telling you, the pharma companies make money by treating a disease, not curing.” How many times have we heard the above or some sort of variation of the above from family, friends, and comedians? For the record, that stopped being funny a long time
Episode 9 – Prof Charles Cooney, the History and Future of Biotech and Boston Ballet
My guest today is Prof Charles Cooney. Prof Cooney received his B.S. in chemical engineering from the University of Pennsylvania in 1966, and the S.M. (1967) and Ph.D. (1970) in biochemical engineering from MIT. He joined the MIT faculty as an assistant professor
Episode 8 – David Sullivan on New Modalities, Price, Patients and the Pharma Landscape
My guest today is David Sullivan, Sr. Director and Global Lead of Vaccines and Biologics MSAT at Pfizer. He did his Bachelor’s in Biotechnology from Worcester Polytechnic Institute and Master’s in Engineering Management from Tufts University. Over the years, he’s worked in process
Episode 7 – Salvatore Mascia and Continuous Manufacturing
My guest today is Salvatore Mascia. Sal is the Co-Founder & CEO of CONTINUUS Pharmaceuticals based in Woburn, MA. He was the former Strategic Project Manager at the Novartis-MIT Center for Continuous Manufacturing, where he led the integration of the first end-to-end continuous
Episode 6 – Matt Roberge and the Global Pharma Forces
My guest today is Matt Roberge. He got his Mechanical Engineering degree from Villanova Uni. He currently works for Pfizer and serves as a senior director of Global technology network and Emerging market. He has a truly global organization with teams in the
Episode 5 – Blockchain and Fake Drugs with Dr. Hariawala, Prof Vaishnav and Mr. Mankodi
Dr. Mukesh Hariawala is a world-renowned heart surgeon, a highly sought after keynote speaker and Chairman of American Healthcare International (AHI). Prof Chintan Vaishnav is a professor at Sloan School of Management at MIT and Director of MIT Tata Center for Technology and